Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-26062

Single-particle
2.39 Å
EMD-26062
3D View Gallery
Deposition: 25/01/2022
Map released: 20/04/2022
Last modified: 28/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-26062
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7tpr summary report (pdf.gz) Map and 7tpr FULL report (pdf.gz)
EMICSS annotations (xml)

Camel nanobodies 7A3 and 8A2 broadly neutralize SARS-CoV-2 variants

EMD-26062

Single-particle
2.39 Å
EMD-26062
3D View Gallery
Deposition: 25/01/2022
Map released: 20/04/2022
Last modified: 28/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Camelus dromedarius, Severe acute respiratory syndrome coronavirus 2
Sample: Ternary complex of SARS-Cov-2 Spike protein ectodomain (Wuhan strain) and camel nanobodies 7A3 and 8A2.
Fitted models: 7tpr

Deposition Authors: Butay KJ, Zhu J
Camel nanobodies broadly neutralize SARS-CoV-2 variants
Hong J, Kwon HJ, Cachau R, Chen CZ, Dandey VP, Martin N, Esposito D, Ortega-Rodriguez U, Xu M, Borgnia MJ, Xie H, Ho M
(2021) bioRxiv
PUBMED: 34751270
DOI: doi:10.1101/2021.10.27.465996
ISSN: 2692-8205